Synagis

Sanofi, AstraZeneca mark big leap toward filing of RSV drug in 2022, with safety data in hand to challenge Synagis
Endpoints
Mon, 06/28/21 - 10:58 am
Sanofi
AstraZeneca
RSV
clinical trials
nirsevimab
Synagis
AstraZeneca makes $1B-plus in cash-and-stock deal granting Sobi US rights to RSV drug Synagis
Endpoints
Tue, 11/13/18 - 10:29 am
AstraZeneca
Sobi
Synagis
RSV
The top 10 patent losses of 2015
Fierce Pharma
Fri, 12/19/14 - 08:35 am
patents
Lantus
Abilify
Copaxone
Neulasta
Tracleer
Namenda
Avodart
Jalyn
Zyvox
Androgel
Synagis
Sanofi
Bristol-Myers Squibb
Otsuka
Teva Pharmaceutical
Amgen
Actelion
Actavis
GSK
Pfizer
AbbVie
AstraZeneca
Virus drugmaker fights pediatricians' new advice
Yahoo/AP
Mon, 07/28/14 - 11:11 am
MedImmune
premature infants
Synagis
RSV
PDL Settles MedImmune Dispute
Yahoo/Zacks.com
Fri, 02/18/11 - 03:17 pm
PDL Biopharma
MedImmune
AstraZeneca
RSV
Synagis
Abbott Laboratories
PDLI's Synagis Lawsuit Invalidated
Yahoo/Zacks.com
Tue, 01/11/11 - 02:37 pm
Synagis
PDL Biopharma
MedImmune
lawsuits
Abbott Laboratories
Deals to Be Done After AstraZeneca Setback
WSJ Online
Thu, 12/23/10 - 08:26 am
AstraZeneca
RSV
Cubist Pharmaceuticals
NanoBio
MicroDose Therapeutx
Novavax
Synagis
motavizumab
Alnylam
Synagis' Special Status Under Health Care Reform
InVivo
Tue, 08/24/10 - 07:23 am
RSV
MedImmune
Synagis
AstraZeneca
AstraZeneca Learns the FDA May Have Gotten Wise to Copy-Cat Drugs
BNET Pharma
Mon, 06/7/10 - 07:55 am
AstraZeneca
FDA
copycat drugs
RSV
Synagis
Rezield
MedImmune responds to FDA on pediatric drug
Bizjournals.com
Mon, 12/28/09 - 04:42 am
FDA
MedImmune
Synagis
RSV
PDL BioPharma rises on better-than-seen outlook
Yahoo/AP
Mon, 06/8/09 - 11:17 am
PDL Biopharma
Avastin
Synagis